Atlantic Biologicals Corporation Enters into Deferred Prosecution Agreement in Opioid Distribution Scheme

FL 2025 Independent Pharmacies

OIG Controlled Substance

Penalty

$2.5 million

Outcome

OIG enforcement action against Atlantic Biologicals Corporation Enters into Deferred Prosecution Agreement in Opioid Distribution Scheme for controlled substance. Penalty: $2.5 million.

Details

Atlantic Biologicals Corporation Enters into Deferred Prosecution Agreement in Opioid Distribution Scheme — OIG Enforcement (2025)

OIG took enforcement action against Atlantic Biologicals Corporation Enters into Deferred Prosecution Agreement in Opioid Distribution Scheme in FL in 2025 involving controlled substance violations in the Independent Pharmacies sector.

Penalty: $2.5 million

Violation types: Controlled Substance
Entity type: Pharmacy
Penalty type: Criminal
Location: FL

Source: Atlantic Biologicals Corporation Enters into Deferred Prosecution Agreement in Opioid Distribution Scheme

How Crucible Prevents This

Crucible's controlled substance tracking enforces DEA-compliant inventory reconciliation, flags prescribing pattern anomalies, and requires segregation of duties for dispensing and record-keeping.

Source: Atlantic Biologicals Corporation Enters into Deferred Prosecution Agreement in Opioid Distribution Scheme

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works